findmyKOL
Clinical trialNCT03587272RecruitingPhase 2Interventional

Minimizing Toxicity in HLA-identical Sibling Donor Transplantation for Children With Sickle Cell Disease

SponsorRobert NickelEnrollment100Sickle Cell Disease
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

7 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Canada
  • Alberta Children'S Hospital

    Calgary, Alberta, Canada

    Gregory Guilcher, MD
    Recruiting
  • the Hospital for Sick Children

    Toronto, Ontario, Canada

    Muhammad Ali, MD
    Recruiting
United States
  • Children'S National Health System

    Washington D.C., District of Columbia, United States

    Robert Nickel, MD
    Recruiting
  • Ann & Robert H. Lurie Children'S Hospital of Chicago

    Chicago, Illinois, United States

    Sonali Chaudhury, MD
    Recruiting
  • Columbia University

    New York, New York, United States

    Monica Bhatia
    Recruiting
  • Levine Children'S Hospital

    Charlotte, North Carolina, United States

    Michael Kent, MD
    Recruiting
  • Nationwide Children'S Hospital

    Columbus, Ohio, United States

    Hemalatha Rangarajan, MD
    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
17 Apr 2018
Primary completion
30 Nov 2030
Completion
30 Nov 2030
Last update posted
10 Mar 2026
Registered enrollment
100
Registry id
NCT03587272

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.